epicatechin gallate has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arlt, A; Goumas, F; Heise, D; Kalthoff, H; Kürbitz, C; Lemke, J; Redmer, T; Rimbach, G; Trauzold, A | 1 |
1 other study(ies) available for epicatechin gallate and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Blotting, Western; Carcinoma, Pancreatic Ductal; Catechin; Cell Cycle; Cell Proliferation; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Antibody Technique; Humans; Pancreatic Neoplasms; Tea; Tumor Cells, Cultured | 2011 |